Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort
Yan Jin, Qianqian Xue, Xuxia Shen, et al.
Clinical Lung Cancer (2021) Vol. 23, Iss. 1, pp. 43-51
Closed Access | Times Cited: 15

Showing 15 citing articles:

Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study
Hanmin Wang, Chan-Yuan Zhang, Kai‐Cheng Peng, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 2, pp. 100911-100911
Open Access | Times Cited: 90
Design of PD‐L1‐Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy
Yelee Kim, Jiwoong Choi, Eun Hye Kim, et al.
Advanced Science (2024) Vol. 11, Iss. 22
Open Access | Times Cited: 19
Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy
Maritza Ramos-Ramírez, Enrique Caballé‐Perez, José Lucio-Lozada, et al.
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Closed Access | Times Cited: 1
TP53 Co-Mutations in Advanced EGFR-Mutated Non–Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy
Surui Liu, Jin Yu, Hui Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 31
Response and acquired resistance to MET inhibitors in de novo MET fusion-positive advanced non-small cell lung cancer
Jin U. Kang, Qiu‐Mei Deng, Weineng Feng, et al.
Lung Cancer (2023) Vol. 178, pp. 66-74
Closed Access | Times Cited: 22
The significance of co-mutations in EGFR-mutated non-small cell lung cancer: Optimizing the efficacy of targeted therapies?
Federica Pezzuto, Véronique Hofman, Christophe Bontoux, et al.
Lung Cancer (2023) Vol. 181, pp. 107249-107249
Open Access | Times Cited: 14
Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC
Lanlan Pang, Yihua Huang, Weitao Zhuang, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 12, pp. 2636-2646
Open Access | Times Cited: 5
PD‐L1 Scoring Models for Non‐Small Cell Lung Cancer in China: Current Status, AI‐Assisted Solutions and Future Perspectives
Ziling Huang, Shen Wang, Jiansong Zhou, et al.
Thoracic Cancer (2025) Vol. 16, Iss. 7
Open Access
Cell Culture Model Evolution and Its Impact on Improving Therapy Efficiency in Lung Cancer
Viviana Roman, Mirela Mihăilă, Nicoleta Radu, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4996-4996
Open Access | Times Cited: 10
A new AI-assisted scoring system for PD-L1 expression in NSCLC
Ziling Huang, Lijun Chen, Lei Lv, et al.
Computer Methods and Programs in Biomedicine (2022) Vol. 221, pp. 106829-106829
Closed Access | Times Cited: 16
Correlation of PD-L1 expression on tumour cells between diagnostic biopsies and surgical specimens of lung cancer in real life with respect to biopsy techniques and neoadjuvant treatment
Daniela Gompelmann, Katharina Sinn, J. Brugger, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 5, pp. 1747-1754
Open Access | Times Cited: 8
PD-L1 Expression and Tumour Microenvironment Patterns in Resected Non-Small-Cell Lung Cancer
Giedrė Gurevičienė, Jurgita Matulionė, Lina Poškienė, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 482-482
Open Access | Times Cited: 1
Epidermal growth factor receptor compound and concomitant mutations: advances in precision treatment strategies
Wenqian Li, Rilan Bai, Hanfei Guo, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 2
Real-world outcomes of chemoimmunotherapy and selective RET inhibitors in Chinese patients with RET fusion-positive non-small cell lung cancer
Rui Wan, Weihua Li, Zhijie Wang, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24796-e24796
Open Access
Response to ABCP Regimen in a ROS1Rearranged Lung Adenocarcinoma Patient with Brain Metastases and High PD-L1 Expression: A Case Report
Quan-Quan Tan, Yuqing Chen, Ming-Ying Zheng, et al.
Journal of Oncology Research and Therapy (2022) Vol. 7, Iss. 4
Open Access
Page 1

Scroll to top